Biogen’s head-scratching new lobbyist hire

Biogen, the company behind the embattled Alzheimer’s drug Aduhelm, has hired a new lobbyist focused on Alzheimer’s advocacy, but he’s not necessarily the type of expert you’d expect.

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Your quarterly dose of lobbying gossip

Read the rest…